Firefly Neuroscience (AIFF) said Tuesday it has obtained up to $12.4 million in new funding to support the commercialization of the company's Brain Network Analytics technology and for general working capital purposes.
The funding comprises $2.4 million upfront in senior convertible notes at $3 per share, together with an equity line of credit for up to $10 million, the company said.
Firefly Neuroscience shares were nearly 3% higher in recent Tuesday trading.